Related Experiment Video
Updated: Aug 15, 2026

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
Methamphetamine and alcohol abuse and dependence symptoms: associations with affect lability and impulsivity in a
Jeffrey S Simons1, Matthew N I Oliver, Raluca M Gaher
1Department of Psychology, University of South Dakota, 414 East Clark St., Vermillion, South Dakota 57069, United States. jsimons@usd.edu
Abstract:
The present study examined associations between impulsivity and affect lability and methamphetamine and alcohol abuse and dependence symptoms in a rural inpatient treatment population (N=235). Thirty-two percent of participants reported methamphetamine use in the past 90 days prior to admission. Amphetamine use disorders were found to be more common among younger participants whereas alcohol use disorders were more common among older and Native American participants. After controlling for age, gender, use frequency, and injection use, impulsivity but not affect lability was associated with methamphetamine abuse but not dependence symptoms. Lability but not impulsivity was associated with alcohol dependence but not abuse symptoms after controlling for age, gender, and use frequency. Consistent with past epidemiological studies, results indicate that methamphetamine use is a prominent problem facing rural substance use treatment facilities. Affect lability and impulsivity are associated with methamphetamine and alcohol-related problems in this population.
More Related Videos
Related Concept Videos
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

